WVE
Wave Life Sciences Ltd
NASDAQ: WVE · HEALTHCARE · BIOTECHNOLOGY
$4.59
-1.71% today
Updated 2026-09-11
Market cap
$947.80M
P/E ratio
—
P/S ratio
14.50x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$5 – $22
Volume
3.0M
Wave Life Sciences Ltd (WVE) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.59
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$113.98
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 16.31% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.